Hong Kong must woo mainland tech firms, boost small firms’ market turnover: chamber


The Hong Kong government should appeal to up and coming mainland technology companies to move part of their operations to the city and introduce measures to boost the market turnover of smaller listed companies, according to the chairman of the Hong Kong Chamber of Listed Companies (HKCLC).

The chamber floated these recommendations to Chief Executive John Lee Ka-chiu during a recent consultation session ahead of his Policy Address on Wednesday.

“Hong Kong’s listing reforms have already attracted a lot of mainland technology and biotechnology firms to list here in recent years, while there are 200 listing candidates in the pipeline,” said Chan Ka-keung on Thursday in his first interview since becoming chairman in June.

He said that while many of these listed companies used the listing proceeds to expand their mainland or international businesses, the chamber would like to see these firms use some of the funds to set up offices or relocate some business activities to Hong Kong.

Hong Kong’s daily market turnover increased 132 per cent in the first eight months to HK$248.3 billion. Photo: Sun Yeung
Hong Kong’s daily market turnover increased 132 per cent in the first eight months to HK$248.3 billion. Photo: Sun Yeung

“If these mainland start-ups have more of their operations in Hong Kong, it would provide more job opportunities for locals and support the city’s economy,” said Chan, Hong Kong’s former secretary for financial services and the treasury from 2007 to 2017.

Bourse operator Hong Kong Exchanges and Clearing’s (HKEX) in 2018 introduced reforms allowing companies with multiple classes of voting rights and pre-revenue biotech firms to list here. That was followed by Chapter 18C in March 2023, which allows large tech companies to list even if they have made no revenue.

  • Related Posts

    China’s first-tier home prices stabilise in February after 9 months of decline

    Mainland China’s first-tier new home prices were unchanged month on month in February, ending a nine-month decline, while the year-on-year decline continued to widen from tier one to tier three…

    Continue reading
    Hong Kong attracts wave of biotech IPO filings amid AI drug boom

    More than 10 loss-making biotechnology companies have filed for Hong Kong stock exchange listings this year, bringing cutting-edge drugs and artificial intelligence-powered drug discovery platforms to market, as the city’s…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *